Rönnbäck Cecilia, Nissen Claus, Almind Gitte J, Grønskov Karen, Milea Dan, Larsen Michael
Department of Ophthalmology, Glostrup Hospital, Glostrup, Denmark.
Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Acta Ophthalmol. 2015 Dec;93(8):762-6. doi: 10.1111/aos.12835. Epub 2015 Sep 19.
To describe the thickness of the combined ganglion cell and inner plexiform layers (GC-IPL) and the peripapillary retinal nerve fibre layer (RNFL) in patients with OPA1 c.983A>G or c.2708_2711delTTAG autosomal-dominant optic atrophy (ADOA).
The study included 20 individuals with c.983A>G and nine individuals with c.2708_2711delTTAG. Data for comparison were drawn from 49, previously published, individuals with OPA1 c.2826_2836delinsGGATGCTCCA and 51 individuals with no OPA1 mutation. Subjects underwent refraction, best-corrected visual acuity assessment, axial length measurement and high-definition optical coherence tomography.
There was overlap in GC-IPL thickness in subjects younger than 20-30 years between the two new groups of ADOA patients and controls. Numerical decreases in GC-IPL thickness with age did not reach statistical significance in individuals with c.983A>G (p = 0.18) or in healthy controls (p = 0.22), but it did in individuals with c.2708_2711delTTAG (p = 0.02). Visual acuity decreased with decreasing GC-IPL thickness (p = 0.0006 in c.983A>G and p = 0.0084 in c.2708_2711delTTAG). Unlike c.2826_2836delinsGGATGCTCCA, individuals with c.983A>G or c.2708_2711delTTAG did not show a pattern of maximum GC-IPL deficit inferonasal of the fovea.
Genotype-phenotype heterogeneity in OPA1 ADOA is evident when inner retinal atrophy is examined as a function of age. Thus, a pronounced decline with age in GC-IPL thickness is observed in c.2708_2711delTTAG ADOA, an intermediate decline with age is observed in c.983A>G ADOA, whereas little or no change with age is observed in c.2826_2836delinsGGATGCTCCA ADOA. This genotype-phenotype heterogeneity may explain why some patients have progressive visual loss while others have a relatively stable prognosis.
描述携带OPA1基因c.983A>G或c.2708_2711delTTAG突变的常染色体显性遗传性视神经萎缩(ADOA)患者的神经节细胞与内网状层(GC-IPL)以及视乳头周围视网膜神经纤维层(RNFL)的厚度。
该研究纳入了20例携带c.983A>G突变的个体和9例携带c.2708_2711delTTAG突变的个体。用于比较的数据来自49例先前已发表的携带OPA1基因c.2826_2836delinsGGATGCTCCA突变的个体以及51例无OPA1基因突变的个体。受试者接受了验光、最佳矫正视力评估、眼轴长度测量以及高清光学相干断层扫描检查。
在20至30岁以下的ADOA患者新组与对照组之间,GC-IPL厚度存在重叠。在携带c.983A>G突变的个体(p = 0.18)或健康对照组(p = 0.22)中,GC-IPL厚度随年龄的数值下降未达到统计学意义,但在携带c.2708_2711delTTAG突变的个体中达到了统计学意义(p = 0.02)。视力随着GC-IPL厚度的降低而下降(携带c.983A>G突变者p = 0.0006,携带c.2708_2711delTTAG突变者p = 0.0084)。与携带c.2826_2836delinsGGATGCTCCA突变的个体不同,携带c.983A>G或c.2708_2711delTTAG突变的个体在中央凹鼻下侧未表现出GC-IPL最大缺损的模式。
当将视网膜内层萎缩作为年龄的函数进行研究时,OPA1 ADOA的基因型-表型异质性很明显。因此,在携带c.2708_2711delTTAG突变的ADOA患者中观察到GC-IPL厚度随年龄有明显下降,在携带c.983A>G突变的ADOA患者中观察到随年龄有中度下降,而在携带c.2826_2836delinsGGATGCTCCA突变的ADOA患者中观察到随年龄几乎没有变化或没有变化。这种基因型-表型异质性可能解释了为什么一些患者会出现进行性视力丧失,而另一些患者的预后相对稳定。